The regulatory role of dendritic cells in the immune response

International Archives of Allergy and Immunology

Volumn 134, Issue 3, 2004, Pages 179-185

  Granucci, Francesca ^a   Zanoni, Ivan ^a   Feau, Sonia ^a   Capuano, Giusy ^a   Ricciardi Castagnoli, Paola ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Cytoskeleton; Dendritic cells; Immune response, adaptive; Immune response, innate; Interleukin 2

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD11B ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 2; MANNOSE RECEPTOR; SCAVENGER RECEPTOR; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA;

ACTIN FILAMENT; ANTIBODY COMBINING SITE; ANTIBODY PRODUCING CELL; ANTIBODY PRODUCTION; ANTIBODY STRUCTURE; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; APOPTOSIS; CELL MATURATION; CELL MOTILITY; CELL SURVIVAL; COMPLEMENT ACTIVATION; DENDRITIC CELL; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOREGULATION; INFECTION SENSITIVITY; LYMPHOCYTE PROLIFERATION; MOLECULAR RECOGNITION; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION; STRUCTURAL HOMOLOGY; TH1 CELL;

ANIMALS; CELL DIFFERENTIATION; DENDRITIC CELLS; HUMANS; INTERLEUKIN-2; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 3042625962     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000078764     Document Type: Review

References (57)

1. Steinman RM: The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991;9:271-296.
2. Steinman RM, Hawiger D, Nussenzweig MC: Tolerogenic dendritic cells. Annu Rev Immunol 2003;21:685-711.
3. Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature 1998;392:245-252.
4. Sallusto F, Lanzavecchia A: Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994;179:1109-1118.
5. Winzler C, Rovere P, Rescigno M, Granucci F, Penna G, Adorini L, et al: Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J Exp Med 1997;185:317-328.
6. Granucci F, Vizzardelli C, Pavelka N, Feau S, Persico M, Virzi E, et al: Inducible IL-2 production by dendritic cells revealed by global gene expression analysis. Nat Immunol 2001;2:882-888.
7. Huang Q, Liu D, Majewski P, Schulte LC, Korn JM, Young RA, et al: The plasticity of dendritic cell responses to pathogens and their components. Science 2001;294:870-875.
8. Medzhitov R, Janeway CA Jr: How does the immune system distinguish self from nonself? Semin Immunol 2000;12:185-188, 257-344.
9. Rescigno M, Martino M, Sutherland CL, Gold MR, Ricciardi-Castagnoli P: Dendritic cell survival and maturation are regulated by different signaling pathways. J Exp Med 1998;188:2175-2180.
10. Rescigno M: Dendritic cells and the complexity of microbial infection. Trends Microbiol 2002;10:425-461.
11. Lemaitre B, Nicolas E, Michaut L, Reichhart JM, Hoffmann JA: The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 1996;86:973-983.
12. Akira S: Toll-like receptors and innate immunity. Adv Immunol 2001;78:1-56.
13. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr: A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997;388:394-397.
14. Bendelac A, Medzhitov R: Adjuvants of immunity: Harnessing innate immunity to promote adaptive immunity. J Exp Med 2002;195:F19-F23.
15. Hirschfeld M, Kirschning CJ, Schwandner R, Wesche H, Weis JH, Wooten RM, et al: Cutting edge: Inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2. J Immunol 1999;163:2382-2386.
16. Yoshimura A, Lien E, Ingalls RR, Tuomanen E, Dziarski R, Golenbock D: Cutting edge: Recognition of gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol 1999;163:1-5.
17. Underhill DM, Ozinsky A, Smith KD, Aderem A: Toll-like receptor-2 mediates mycobacteriainduced proinflammatory signaling in macrophages. Proc Natl Acad Sci USA 1999;96:14459-14463.
18. Poltorak A, Smirnova I, He X, Liu MY, Van Huffel C, McNally O, et al: Genetic and physical mapping of the Lps locus: Identification of the toll-4 receptor as a candidate gene in the critical region. Blood Cells Mol Dis 1998;24:340-355.
19. Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T, et al: Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 1999;11:443-451.
20. Hofer S, Rescigno M, Granucci F, Citterio S, Francolini M, Ricciardi-Castagnoli P: Differential activation of NF-kappa B subunits in dendritic cells in response to gram-negative bacteria and to lipopolysaccharide. Microbes Infect 2001;3:259-265.
21. Anderson DC, Freeman KL, Heerdt B, Hughes BJ, Jack RM, Smith CW: Abnormal stimulated adherence of neonatal granulocytes: Impaired induction of surface Mac-1 by chemotactic factors or secretagogues. Blood 1987;70:740-750.
22. Borregaard N, Miller LJ, Springer TA: Chemoattractant-regulated mobilization of a novel intracellular compartment in human neutrophils. Science 1987;237:1204-1206.
23. Tan MC, Mommaas AM, Drijfhout JW, Jordens R, Onderwater JJ, Verwoerd D, et al: Mannose receptor-mediated uptake of antigens strongly enhances HLA class II-restricted antigen presentation by cultured dendritic cells. Eur J Immunol 1997;27:2426-2435.
24. Granucci F, Feau S, Angeli V, Trottein F, Ricciardi-Castagnoli P: Early IL-2 production by mouse dendritic cells is the result of microbialinduced priming. J Immunol 2003;170:5075-5081.
25. Borisy GG, Svitkina TM: Actin machinery: Pushing the envelope. Curr Opin Cell Biol 2000;12:104-112.
26. Movilla N, Bustelo XR: Biological and regulatory properties of Vav-3, a new member of the Vav family of oncoproteins. Mol Cell Biol 1999;19:7870-7885.
27. Elomaa O, Kangas M, Sahlberg C, Tuukkanen J, Sormunen R, Liakka A, et al: Cloning of a novel bacteria-binding receptor structurally related to scavenger receptors and expressed in a subset of macrophages. Cell 1995;80:603-609.
28. Kraal G, van der Laan LJ, Elomaa O, Tryggvason K: The macrophage receptor MARCO. Microbes Infect 2000;2:313-316.
29. Granucci F, Petralia F, Urbano M, Citterio S, Di Tota F, Santambrogio L, et al: The scavenger receptor MARCO mediates cytoskeleton rearrangements in dendritic cells and microglia. Blood 2003;102:2940-2947.
30. Martin F, Kearney JF: Marginal-zone B cells. Nat Rev Immunol 2002;2:323-335.
31. Burns S, Thrasher AJ, Blundell MP, Machesky L, Jones GE: Configuration of human dendritic cell cytoskeleton by Rho GTPases, the WAS protein, and differentiation. Blood 2001;98:1142-1149.
32. Cella M, Engering A, Pinet V, Pieters J, Lanzavecchia A: Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 1997;388:782-787.
33. Rescigno M, Citterio S, Thery C, Rittig M, Medaglini D, Pozzi G, et al: Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells. Proc Natl Acad Sci USA 1998;95:5229-5234.
34. Pierre P, Turley SJ, Gatti E, Hull M, Meltzer J, Mirza A, et al: Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 1997;388:787-792.
35. Garrett WS, Chen LM, Kroschewski R, Ebersold M, Turley S, Trombetta S, et al: Developmental control of endocytosis in dendritic cells by Cdc42. Cell 2000;102:325-334.
36. Granucci F, Vizzardelli C, Virzi E, Rescigno M, Ricciardi-Castagnoli P: Transcriptional reprogramming of dendritic cells by differentiation stimuli. Eur J Immunol 2001;31:2539-2546.
37. Langenkamp A, Messi M, Lanzavecchia A, Sallusto F: Kinetics of dendritic cell activation: Impact on priming of TH1, TH2 and nonpolarized T cells. Nat Immunol 2000;1:311-316.
38. d'Ostiani CF, Del Sero G, Bacci A, Montagnoli C, Spreca A, Mencacci A, et al: Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans. Implications for initiation of T helper cell immunity in vitro and in vivo. J Exp Med 2000;191:1661-1674.
39. Lebecque S: A new job for dendritic cells. Nat Immunol 2001;2:830-831.
40. Grakoui A, Bromley SK, Sumen C, Davis MM, Shaw AS, Allen PM, et al: The immunological synapse: A molecular machine controlling T cell activation. Science 1999;285:221-227.
41. Steinman RM: DC-SIGN: A guide to some mysteries of dendritic cells. Cell 2000;100:491-494.
42. Jung S, Unutmaz D, Wong P, Sano G, De los Santos K, Sparwasser T, et al: In vivo depletion of CD11c(+) dendritic cells abrogates priming of CD8(+) T cells by exogenous cell-associated antigens. Immunity 2002;17:211-220.
43. Andrews DM, Andoniou CE, Granucci F, Ricciardi-Castagnoli P, Degli-Esposti MA: Infection of dendritic cells by murine cytomegalovirus induces functional paralysis. Nat Immunol 2001;2:1077-1084.
44. Smyth MJ, Hayakawa Y, Takeda K, Yagita H: New aspects of natural-killer-cell surveillance and therapy of cancer. Nat Rev Cancer 2002;2:850-861.
45. Moretta A: Natural killer cells and dendritic cells: Rendezvous in abused tissues. Nat Rev Immunol 2002;2:957-964.
46. Ferlazzo G, Tsang ML, Moretta L, Melioli G, Steinman RM, Munz C: Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med 2002;195:343-351.
47. Ferlazzo G, Morandi B, D'Agostino A, Meazza R, Melioli G, Moretta A, et al: The interaction between NK cells and dendritic cells in bacterial infections results in rapid induction of NK cell activation and in the lysis of uninfected dendritic cells. Eur J Immunol 2003;33:306-313.
48. Gerosa F, Baldani-Guerra B, Nisii C, Marchesini V, Carra G, Trinchieri G: Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med 2002;195:327-333.
49. Piccioli D, Sbrana S, Melandri E, Valiante NM: Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J Exp Med 2002;195:335-341.
50. Boehm U, Klamp T, Groot M, Howard JC: Cellular responses to interferon-gamma. Annu Rev Immunol 1997;15:749-795.
51. Fernandez NC, Lozier A, Flament C, Ricciardi-Castagnoli P, Bellet D, Suter M, et al: Dendritic cells directly trigger NK cell functions: Cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med 1999;5:405-411.
52. Van Den Broeke LT, Daschbach E, Thomas EK, Andringa G, Berzofsky JA: Dendritic cellinduced activation of adaptive and innate antitumor immunity. J Immunol 2003;171:5842-5852.
53. Albertsson PA, Basse PH, Hokland M, Goldfarb RH, Nagelkerke JF, Nannmark U, et al: NK cells and the tumour microenvironment: Implications for NK-cell function and antitumour activity. Trends Immunol 2003;24:603-609.
54. Wedemeyer J, Tsai M, Galli SJ: Roles of mast cells and basophils in innate and acquired immunity. Curr Opin Immunol 2000;12:624-631.
55. Galli SJ, Maurer M, Lantz CS: Mast cells as sentinels of innate immunity. Curr Opin Immunol 1999;11:53-59.
56. Henz BM, Maurer M, Lippert U, Worm M, Babina M: Mast cells as initiators of immunity and host defense. Exp Dermatol 2001;10:1-10.
57. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP: Natural killer cells in antiviral defense: Function and regulation by innate cytokines. Annu Rev Immunol 1999;17:189-220.